Tradestie Institutional Equity Comparison Engine
VTAK vs TVGN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TVGN Overall Edge
TVGN Captures Institutional Edge (2โ0 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tevogen Bio Holdings Inc. Common Stock (TVGN) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, VTAK trades at N/M Forward P/E with -388.1% operating margin (+380.7% YoY revenue) versus TVGN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, VTAK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TVGN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
VTAK N/M vs TVGN N/M Fwd P/E
Growth & Margin Winner
TVGN
Op Margin -388.1% vs 0.0% ยท YoY +380.7% vs +0.0%
Momentum & Technical Winner
TVGN
1Y -94.3% vs +1198.4% ยท 52W Pos 1% vs 47%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
VTAK
NYSE American
Catheter Precision, Inc.
Surgical & Medical Instruments & Apparatus
$0.15
-0.66% 1D
Market Cap
$548,639
1M Return
-24.76%
1Y Return
-94.28%
Forward P/E
N/M
Unified AI Score
58.1 / 100
HOLD
Tech 72.0
Fund 70.0
Flow 50.0
Mom 60.0
TVGN
NASDAQ
Tevogen Bio Holdings Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$5.76
-7.32% 1D
Market Cap
$406.6M
1M Return
-14.84%
1Y Return
+1198.42%
Forward P/E
N/M
Unified AI Score
49.5 / 100
HOLD
Tech 57.0
Fund 56.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
VTAK -94.28%
TVGN +1198.42%
Spread: +1564.7 pp (TVGN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
VTAK TTM Op. Margin: -388.1%
TVGN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VTAK vs TVGN. Trailing 12-month operating profitability (VTAK -388.1% vs TVGN 0.0%) and valuation multiples (VTAK N/M vs TVGN N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VTAK | TVGN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $548,639 | $406.6M | Larger Scale | TVGN |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +380.7% | +0.0% | Higher Growth | VTAK |
| Operating Margin (TTM) Profitability | -388.1% | 0.0% | Higher Margin | TVGN |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -111.3% | 0.0% | Higher ROE | TVGN |
| 52-Week Range Position Momentum | 1% ($0โ$3) | 47% ($0โ$12) | Stronger Trend | TVGN |
| Beta / 30D Volatility Risk Regime | 0.19ฮฒ ยท 76% Vol | 1.56ฮฒ ยท 62% Vol | Lower Realized Risk | TVGN |
| Unified Institutional Score Composite Signal | 58.1 / 100 (HOLD) | 49.5 / 100 (HOLD) | Higher Composite | VTAK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full VTAK vs TVGN Buy Guide
VTAK
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
TVGN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither VTAK nor TVGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.